Literature DB >> 11853876

The alpha5beta1 integrin selectively enhances epidermal growth factor signaling to the phosphatidylinositol-3-kinase/Akt pathway in intestinal epithelial cells.

Jung Weon Lee1, R L Juliano.   

Abstract

We have investigated EGF-driven signaling processes in rat intestinal epithelial cell lines that overexpress either the alpha5beta1 integrin or the alpha2beta1 integrin. Both cell types display efficient activation of Erk/MAP kinase, but only the alpha5beta1 expressing cells display a strong activation of Akt. A complex is formed between activated EGFR and alpha5beta1, but not with alpha2beta1; this complex also contains ErbB3 and p85. Thus alpha5beta1 can support efficient activation of both the Erk and the phosphatidylinositol-3-kinase/Akt branches of the EGFR signaling cascade, whereas alpha2beta1 can support only the Erk branch.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11853876     DOI: 10.1016/s0167-4889(01)00161-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  Autocrine-controlled formation and function of tissue-like aggregates by primary hepatocytes in micropatterned hydrogel arrays.

Authors:  Courtney M Williams; Geeta Mehta; Shelly R Peyton; Adam S Zeiger; Krystyn J Van Vliet; Linda G Griffith
Journal:  Tissue Eng Part A       Date:  2011-02-02       Impact factor: 3.845

2.  The signaling network of transforming growth factor beta1, protein kinase Cdelta, and integrin underlies the spreading and invasiveness of gastric carcinoma cells.

Authors:  Mi-Sook Lee; Tae Young Kim; Yong-Bae Kim; Sung-Yul Lee; Seong-Gyu Ko; Hyun-Soon Jong; Tae-You Kim; Yung-Jue Bang; Jung Weon Lee
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

3.  Substance P mediates antiapoptotic responses in human colonocytes by Akt activation.

Authors:  Hon-Wai Koon; Dezheng Zhao; Yanai Zhan; Mary P Moyer; Charalabos Pothoulakis
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-30       Impact factor: 11.205

4.  TGF-beta1 (transforming growth factor-beta1)-mediated adhesion of gastric carcinoma cells involves a decrease in Ras/ERKs (extracellular-signal-regulated kinases) cascade activity dependent on c-Src activity.

Authors:  Hwang-Phill Kim; Mi-Sook Lee; Jiyon Yu; Jin-Ah Park; Hyun-Soon Jong; Tae-You Kim; Jung Weon Lee; Yung-Jue Bang
Journal:  Biochem J       Date:  2004-04-01       Impact factor: 3.857

5.  Effects of angiopoietin-1 on attachment and metastasis of human gastric cancer cell line BGC-823.

Authors:  Xi-Long Ou; Hui-Juan Chen; Wei-Hao Sun; Cheng Hang; Liu Yang; Yun-Yan Guan; Fang Yan; Bao-An Chen
Journal:  World J Gastroenterol       Date:  2009-11-21       Impact factor: 5.742

6.  Cell surface integrin α5ß1 clustering negatively regulates receptor tyrosine kinase signaling in colorectal cancer cells via glycogen synthase kinase 3.

Authors:  Alina Starchenko; Ramona Graves-Deal; Douglas Brubaker; Cunxi Li; Yuping Yang; Bhuminder Singh; Robert J Coffey; Douglas A Lauffenburger
Journal:  Integr Biol (Camb)       Date:  2021-06-15       Impact factor: 3.177

7.  Stable interaction between alpha5beta1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1.

Authors:  Ilaria Cascone; Lucia Napione; Fabrizio Maniero; Guido Serini; Federico Bussolino
Journal:  J Cell Biol       Date:  2005-09-12       Impact factor: 10.539

8.  CH-ILKBP regulates cell survival by facilitating the membrane translocation of protein kinase B/Akt.

Authors:  Tomohiko Fukuda; Lida Guo; Xiaohua Shi; Chuanyue Wu
Journal:  J Cell Biol       Date:  2003-03-24       Impact factor: 10.539

9.  TGFbeta1 signaling via alphaVbeta6 integrin.

Authors:  Martin P Kracklauer; Christian Schmidt; Guido M Sclabas
Journal:  Mol Cancer       Date:  2003-08-07       Impact factor: 27.401

10.  BRAF Inhibition Generates a Host-Tumor Niche that Mediates Therapeutic Escape.

Authors:  Inna V Fedorenko; Jennifer A Wargo; Keith T Flaherty; Jane L Messina; Keiran S M Smalley
Journal:  J Invest Dermatol       Date:  2015-08-24       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.